Is Macrobid (nitrofurantoin) effective against Staphylococcus saprophyticus in urinary tract infections (UTIs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Effectiveness of Macrobid (Nitrofurantoin) Against Staphylococcus saprophyticus

Macrobid (nitrofurantoin) is effective against Staphylococcus saprophyticus and is recommended as a first-line treatment for uncomplicated urinary tract infections where this pathogen is commonly found. 1, 2

Efficacy Against S. saprophyticus

Nitrofurantoin demonstrates good activity against several common uropathogens, including:

  • Escherichia coli (most common UTI pathogen)
  • Staphylococcus saprophyticus (second most common cause of UTIs in women)
  • Enterococcus species 2

Despite its long-term use since the 1950s, nitrofurantoin has maintained its effectiveness against S. saprophyticus, which is particularly important as resistance to other antibiotics increases 2, 3.

Treatment Recommendations

The American Urological Association and other guideline bodies recommend nitrofurantoin as a first-line antibiotic for uncomplicated UTIs 1. The standard dosing regimen is:

Agent Dose Duration
Nitrofurantoin 100mg twice daily 5 days

This recommendation is supported by high-quality evidence (level I) 1.

Advantages of Nitrofurantoin for S. saprophyticus UTIs

  1. Maintained effectiveness: Unlike trimethoprim-sulfamethoxazole and fluoroquinolones, which have seen increasing resistance rates, nitrofurantoin has retained good activity against S. saprophyticus 2, 3

  2. Lower resistance development: The limited systemic distribution and multiple mechanisms of action of nitrofurantoin contribute to lower rates of resistance development 4

  3. Broad-spectrum activity: Effective against both gram-positive (including S. saprophyticus) and gram-negative uropathogens 4

Important Contraindications and Limitations

Nitrofurantoin should not be used in:

  • Patients with renal impairment (CrCl <60 mL/min)
  • Pregnancy at term (38-42 weeks)
  • Patients with G6PD deficiency
  • Patients with a history of pulmonary reactions to nitrofurantoin 1

Additionally, nitrofurantoin is not appropriate for:

  • Complicated UTIs with systemic symptoms
  • Pyelonephritis
  • Prostatitis 1, 5

Adverse Effects to Monitor

  • Common: Mild gastrointestinal disturbances, skin rash
  • Rare but serious: Pulmonary reactions (0.001%), hepatic toxicity (0.0003%) 1

Clinical Pearls

  1. Nitrofurantoin should be taken with food to improve absorption and reduce gastrointestinal side effects

  2. While some guidelines suggest limiting nitrofurantoin use in men due to concerns about prostate involvement, recent evidence suggests it may be a valuable option for uncomplicated UTIs in men without systemic symptoms 5

  3. The Centers for Disease Control and Prevention advises avoiding fluoroquinolones for uncomplicated UTIs due to increasing resistance and risk of serious adverse effects, making nitrofurantoin an increasingly important treatment option 1

  4. For recurrent UTIs, nitrofurantoin can also be considered for prophylaxis when non-antimicrobial interventions have failed 1

In summary, nitrofurantoin (Macrobid) is an effective antibiotic against S. saprophyticus and remains a recommended first-line treatment for uncomplicated UTIs where this pathogen is commonly encountered.

References

Guideline

Urinary Tract Infection Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Nitrofurantoin--clinical relevance in uncomplicated urinary tract infections].

Medizinische Monatsschrift fur Pharmazeuten, 2014

Research

[Nitrofurantoin for urinary tract infections in men: it is possible].

Nederlands tijdschrift voor geneeskunde, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.